| Literature DB >> 26171396 |
Takayuki Ueno1, Jun Utsumi2, Masakazu Toi3, Kazuharu Shimizu4.
Abstract
The microenvironment of cancer cells has been implicated in cancer development and progression. Cancer-associated fibroblast constitutes a major stromal component of the microenvironment. To analyze interaction between cancer cells and fibroblasts, we have developed a new bilateral coculture system using a two-sided microporous collagen membrane. Human normal skin fibroblasts were cocultured with three different human breast cancer cell lines: MCF-7, SK-BR-3, and HCC1937. After coculture, mRNA was extracted separately from cancer cells and fibroblasts and applied to transcriptomic analysis with microarray. Top 500 commonly up- or downregulated genes were characterized by enrichment functional analysis using MetaCore Functional Analysis. Most of the genes upregulated in cancer cells were downregulated in fibroblasts while most of the genes downregulated in cancer cells were upregulated in fibroblasts, indicating that changing patterns of mRNA expression were reciprocal between cancer cells and fibroblasts. In coculture, breast cancer cells commonly increased genes related to mitotic response and TCA pathway while fibroblasts increased genes related to carbohydrate metabolism including glycolysis, glycogenesis, and glucose transport, indicating that fibroblasts support cancer cell proliferation by supplying energy sources. We propose that the bilateral coculture system using collagen membrane is useful to study interactions between cancer cells and stromal cells by mimicking in vivo tumor microenvironment.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26171396 PMCID: PMC4480803 DOI: 10.1155/2015/960840
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1A concept view of bilateral coculture system and flow of experimental procedures. Breast cancer cells and fibroblasts were cocultured on each side of the bilateral microporous collagen matrix membrane. A suspending two-sided microporous collagen membrane with polystyrene reinforced outer frame was positioned in the culture medium in 50 mm diameter culture vessel. Cells were cultured as shown in the microscopic photo. Analytical flow is as illustrated by employing transcriptomic and bioinformatics analyses.
Figure 2Electron microscopic views of cells in coculture. (a) Fibroblasts were cocultured with HCC1937 breast cancer cells (lower photo). As a control, fibroblasts were cultured with fibroblasts (upper photo). In coculture with HCC1937 cells, morphological change of cellular body shape and vacuole-like spaces were observed. (b) HCC1937 breast cancer cells were cocultured with fibroblasts (lower photo). As a control, HCC1937 cells were cultured with HCC1937 cells (upper photo). By coculture with fibroblasts, morphological changes of round shape were observed. Optical microscopic photos were shown at the top right corner.
Figure 3Alteration in individual gene expression in HCC1937 cells and fibroblasts in coculture. (a) Upregulated gene expression profile of mRNA in cocultured HCC1937 breast cancer cells and changes of corresponding genes in fibroblasts. (b) Downregulated gene expression profile of mRNA in cocultured HCC1937 breast cancer cells and changes of corresponding genes in fibroblasts.
Enrichment analysis: upregulation in each cancer cell line.
| # | Upregulation: GO processes in MCF7 |
| FDR |
|---|---|---|---|
| 1 | Cellular process | 2.840 | 8.455 |
| 2 | Protein localization to cell junction | 1.219 | 1.814 |
| 3 | Regulation of cardiac muscle cell apoptotic process | 2.189 | 2.172 |
|
| |||
| # | Upregulation: GO processes in SKBR3 |
| FDR |
|
| |||
| 1 | Cell cycle | 1.192 | 3.578 |
| 2 | Apoptotic process | 5.228 | 4.644 |
| 3 | Cellular metabolic process | 6.045 | 4.644 |
|
| |||
| # | Upregulation: GO processes in HCC1937 |
| FDR |
|
| |||
| 1 | Nuclear division | 1.054 | 2.428 |
| 2 | Organelle fission | 2.879 | 3.317 |
| 3 | Cell division | 1.106 | 8.495 |
|
| |||
| # | Upregulation: metabolic networks in MCF7 |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_TCA and tricarboxylic acids transport | 6.670 | 3.936 |
| 2 | Carbohydrate metabolism_propionate metabolism and transport | 7.222 | 3.936 |
| 3 | Vitamin, mediator, and cofactor metabolism_folic acid | 1.949 | 4.310 |
|
| |||
| # | Upregulation: metabolic networks in SKBR3 |
| FDR |
|
| |||
| 1 | 1-Hexadecanoyl-glycerol_3-phosphate pathway | 7.085 | 4.411 |
| 2 | 1-Linoleoyl-glycerol_3-phosphate pathway | 1.357 | 4.411 |
| 3 | 1-Oleoyl-glycerol_3-phosphate pathway | 1.030 | 2.231 |
|
| |||
| # | Upregulation: metabolic networks in HCC1937 |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_pyruvate metabolism and transport | 6.259 | 2.072 |
| 2 | Lipid metabolism_triacylglycerol metabolism | 1.271 | 2.072 |
| 3 | N-Acetyl-D-galactosamine pathway | 6.763 | 2.072 |
Enrichment analysis: downregulation in each cancer cell line.
| # | Downregulation: GO processes in MCF7 |
| FDR |
|---|---|---|---|
| 1 | Establishment of localization | 2.679 | 2.740 |
| 2 | Transport | 3.991 | 2.740 |
| 3 | Peptidylglycine modification | 6.089 | 2.740 |
|
| |||
| # | Downregulation: GO processes in SKBR3 |
| FDR |
|
| |||
| 1 | Regulation of apoptotic process | 1.195 | 1.799 |
| 2 | Regulation of programmed cell death | 1.578 | 1.799 |
| 3 | Response to mechanical stimulus | 1.664 | 1.799 |
|
| |||
| # | Downregulation: GO processes in HCC1937 |
| FDR |
|
| |||
| 1 | Acute inflammatory response | 9.865 | 2.218 |
| 2 | Response to metal ion | 1.618 | 1.818 |
| 3 | Response to inorganic substance | 2.566 | 1.923 |
|
| |||
| # | Downregulation: metabolic networks in MCF7 |
| FDR |
|
| |||
| 1 | Lysophosphatidylserine pathway | 8.304 | 2.574 |
| 2 | Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport | 3.844 | 5.958 |
| 3 | 1,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway | 1.913 | 1.158 |
|
| |||
| # | Downregulation: metabolic networks in SKBR3 |
| FDR |
|
| |||
| 1 | GalNAcbeta1-3Gal pathway | 5.291 | 3.122 |
| 2 | Pentose phosphate pathways and transport | 1.247 | 3.677 |
| 3 | (L)-Alanine pathways and transport | 9.059 | 1.782 |
|
| |||
| # | Downregulation: metabolic networks in HCC1937 |
| FDR |
|
| |||
| 1 | Phosphatidylethanolamine pathway | 5.054 | 5.559 |
| 2 | O-Hexanoyl-(L)-carnitine pathway | 5.897 | 2.359 |
| 3 | Myristoyl-L-carnitine pathway | 6.435 | 2.359 |
Enrichment analysis: upregulation in fibroblasts.
| # | Upregulation: GO processes with MCF7 |
| FDR |
|---|---|---|---|
| 1 | Regulation of programmed cell death | 1.104 | 3.326 |
| 2 | Regulation of cell death | 5.311 | 8.004 |
| 3 | Regulation of apoptotic process | 3.070 | 3.085 |
|
| |||
| # | Upregulation: GO processes with SKBR3 |
| FDR |
|
| |||
| 1 | Cellular component organization | 8.231 | 2.156 |
| 2 | Cellular component organization or biogenesis | 2.519 | 3.299 |
| 3 | Response to stress | 3.864 | 3.373 |
|
| |||
| # | Upregulation: GO processes with HCC1937 |
| FDR |
|
| |||
| 1 | Single-organism cellular process | 2.687 | 4.223 |
| 2 | Single-organism process | 2.848 | 4.223 |
| 3 | Response to hypoxia | 6.596 | 4.909 |
|
| |||
| # | Upregulation: metabolic networks with MCF7 |
| FDR |
|
| |||
| 1 | (S)-Citrulline pathway | 1.930 | 2.277 |
| 2 | Glycine pathways and transport | 1.052 | 6.208 |
| 3 | L-Serine pathways and transport | 1.889 | 7.432 |
|
| |||
| # | Upregulation: metabolic networks with SKBR3 |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport | 1.938 | 4.456 |
| 2 | Carbohydrate metabolism_fructose metabolism and transport | 7.287 | 8.380 |
| 3 | (L)-Alanine pathways and transport | 1.295 | 7.443 |
|
| |||
| # | Upregulation: metabolic networks with HCC1937 |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport | 4.800 | 2.112 |
| 2 | Carbohydrate metabolism_fructose metabolism and transport | 3.818 | 8.400 |
| 3 | Carbohydrate metabolism_galactose metabolism and transport | 4.798 | 7.037 |
Enrichment analysis: downregulation in fibroblasts.
| # | Downregulation: GO processes with MCF7 |
| FDR |
|---|---|---|---|
| 1 | Mitotic cell cycle | 5.614 | 1.698 |
| 2 | Cell cycle | 7.592 | 1.148 |
| 3 | Mitotic cell cycle process | 3.015 | 3.040 |
|
| |||
| # | Downregulation: GO processes with SKBR3 |
| FDR |
|
| |||
| 1 | Regulation of lipid metabolic process | 1.373 | 5.965 |
| 2 | Positive regulation of biological process | 8.382 | 1.820 |
| 3 | Regulation of protein metabolic process | 1.294 | 1.874 |
|
| |||
| # | Downregulation: GO processes with HCC1937 |
| FDR |
|
| |||
| 1 | Translation | 2.041 | 1.903 |
| 2 | Cellular macromolecular complex assembly | 2.157 | 1.903 |
| 3 | Nuclear-transcribed mRNA catabolic process | 2.488 | 1.313 |
|
| |||
| # | Downregulation: metabolic networks with MCF7 |
| FDR |
|
| |||
| 1 | 2-Oleoyl-glycerol_3-phosphate pathway | 2.569 | 1.079 |
| 2 | Lysophosphatidic acid pathway | 7.980 | 1.676 |
| 3 | 1-Hexadecanoyl-glycerol_3-phosphate pathway | 1.298 | 1.818 |
|
| |||
| # | Downregulation: metabolic networks with SKBR3 |
| FDR |
|
| |||
| 1 | N-Acyl-sphingosine phosphate pathway | 3.589 | 2.441 |
| 2 | 1,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway | 1.119 | 2.836 |
| 3 | 1,2-Dioleoyl-sn-glycerol_3-phosphate pathway | 1.373 | 2.836 |
|
| |||
| # | Downregulation: metabolic networks with HCC1937 |
| FDR |
|
| |||
| 1 | Amino acid metabolism_lysine metabolism and transport | 5.363 | 1.634 |
| 2 | Carbohydrate metabolism_pyruvate metabolism and transport | 1.318 | 1.634 |
| 3 | Glucosylceramide pathways and transport | 1.905 | 1.634 |
| # | Upregulation: GO processes in common of MCF7, SKBR3, and HCC1937 (104 genes) |
| FDR |
|---|---|---|---|
| 1 | Cell cycle | 1.002 | 2.262 |
|
| |||
|
| |||
| 2 | Mitotic cell cycle | 8.624 | 9.732 |
|
| |||
|
| |||
| 3 | Cell cycle process | 1.898 | 1.428 |
|
| |||
|
| |||
| 4 | Mitotic cell cycle process | 4.502 | 2.540 |
|
| |||
|
| |||
| 5 | Cell division | 2.367 | 1.068 |
|
| |||
|
| |||
| # | Upregulation: metabolic networks in common of MCF7, SKBR3, and HCC1937 (104 genes) |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_TCA and tricarboxylic acids transport | 3.939 | 7.900 |
|
| |||
|
| |||
| 2 | Carbohydrate metabolism_propionate metabolism and transport | 4.270 | 7.900 |
|
| |||
|
| |||
| 3 | Amino acid metabolism_lysine metabolism and transport | 8.343 | 1.029 |
|
| |||
|
| |||
| 4 | Phosphatidylcholine pathway | 2.664 | 1.764 |
|
| |||
|
| |||
| 5 | 1,2-Didocosapentaenoyl-sn-glycerol_3-phosphate pathway | 3.305 | 1.764 |
|
| |||
| # | Downregulation: GO processes in common of MCF7, SKBR3, and HCC1937 (105 genes) |
| FDR |
|
| |||
| 1 | Negative regulation of vasoconstriction | 1.343 | 1.091 |
|
| |||
|
| |||
| 2 | Positive regulation of erythrocyte differentiation | 1.876 | 1.143 |
|
| |||
|
| |||
| 3 | Response to mechanical stimulus | 2.787 | 1.358 |
|
| |||
|
| |||
| 4 | Response to radiation | 5.797 | 2.355 |
|
| |||
|
| |||
| 5 | Protein refolding | 6.979 | 2.430 |
|
| |||
|
| |||
| # | Downregulation: metabolic networks in common of MCF7, SKBR3, and HCC1937 (105 genes) |
| FDR |
|
| |||
| 1 | Phosphatides acid pathway | 1.438 | 1.093 |
|
| |||
|
| |||
| 2 | D-Glucuronic acid pathway | 3.958 | 1.504 |
|
| |||
|
| |||
| 3 | Steroid metabolism_pregnenolone and progesterone metabolism | 1.201 | 3.043 |
|
| |||
|
| |||
| 4 | 2-Arachidonoylglycerol_3-phosphocholine pathway | 2.337 | 4.434 |
|
| |||
|
| |||
| 5 | (L)-Leucine pathways and transport | 5.754 | 4.434 |
|
| |||
| Upregulated genes | Downregulated genes | ||||
|---|---|---|---|---|---|
| MCF7 | SKBR3 | HCC1937 | MCF7 | SKBR3 | HCC1937 |
| IFIT1 | PTGS1 | BUB1 | STK19 | DUSP1 | SCGB1A1 |
| AP1B1 | CTSZ | CDCA8 | HMOX1 |
| TF |
| OAT | CYP1B1 | C13orf34 | MEIS3 | EGR1 | C20orf114 |
| ECT2 | ALDH3B2 | ABHD10 | NMT1 | SYCE1 | LYNX1 |
| EFNA1 | SFRS16 | NSMAF | CRK |
| CLCA2 |
| TMEM189-UBE2V1 | BPNT1 | KIF2C | DIABLO | NR4A2 | CASP14 |
| AMH | SLC39A7 | SREBF2 | WDR34 | ENDOD1 | CP |
| NFE2L2 | ATF1 | SLC20A1 | D2HGDH | NR4A1 | EGLN3 |
| PDPK1 | A4GNT | EBNA1BP2 | ATP1B1 | OR14K1 | C7orf29 |
| HSPA8 | BLZF1 | NCAPH | TIMM50 | ATF4 | MATN2 |
| ZNF117 | TUBA3C | TFPI2 | TMEM183A | IFI6 | SERPINA3 |
| GM2A | EXO1 | PHLDA1 | GDI1 | BAK1 | TNFSF10 |
| NUF2 | ST3GAL4 | ATP6V1C1 | TMEM168 | ASNS | TMC4 |
| ANP32A | CSNK2A1 | DDX47 | COX7B | SCNM1 | ANGPTL4 |
| ACYP1 | CARHSP1 | ODC1 | AIFM2 | TPM4 | LY6D |
| RCN2 | C13orf37 | VEGFC | NUP188 | MXD1 | S100A8 |
| STX3 | TRAF4 | GTF2B | DUSP22 | ACTA1 | CHI3L2 |
| TSSC1 | C4orf43 | SLC10A3 | MAK16 | CTGF | KRT15 |
| HEBP1 | DCTPP1 | ALDH7A1 | TROAP |
| PSCA |
| FAM132A | CCAR1 | CDC45L | C19orf46 | ZNF783 | SELENBP1 |
| TMED10 | BAX | FUBP1 |
| CXorf23 |
|
| KTN1 | DSCC1 | GS1-484O17.2 | CLDN4 | ADM | ANKRD37 |
| ACTR6 | YWHAG | CCT8 | SLC25A1 | SREBF2 | CLDN8 |
| AURKA | TEX261 | MEST | ARF1 | ID1 | FBXO32 |
| NGRN | S100A9 | NCAPG | PHF2 | ZG16 | PLXND1 |
| ILK | FAM10A5 | MKI67 | FFAR3 | RGS16 | SERPINA5 |
| STAT1 | FKBP10 | KIAA0101 | SCAF1 | CLIC4 |
|
| PWP1 | ACO2 | SUB1 | C2orf76 | MED12 | NDRG1 |
| PABPC3 | TMSB4X | KIAA1524 | MYOM2 | JUN | CRIP2 |
| SLBP | VWA5B1 | FGF2 | KCTD17 | RNF126 | WFDC2 |
| # | Upregulation: GO processes in common versus MCF7, SKBR3, and HCC1937 (130 genes) |
| FDR |
|---|---|---|---|
| 1 | Single-organism cellular process | 1.586 | 4.679 |
|
| |||
|
| |||
| 2 | Response to organic cyclic compound | 3.170 | 4.679 |
|
| |||
|
| |||
| 3 | Single-organism process | 7.615 | 6.297 |
|
| |||
|
| |||
| 4 | Response to endogenous stimulus | 8.532 | 6.297 |
|
| |||
|
| |||
| 5 | Organic anion transport | 2.208 | 1.304 |
|
| |||
|
| |||
| # | Upregulation: metabolic networks in common versus MCF7, SKBR3, and HCC1937 (130 genes) |
| FDR |
|
| |||
| 1 | Carbohydrate metabolism_glycolysis, glycogenesis, and glucose transport | 9.568 | 4.497 |
|
| |||
|
| |||
| 2 | Carbohydrate metabolism_sucrose metabolism and transport | 4.596 | 7.525 |
|
| |||
|
| |||
| 3 | (L)-Proline pathways and transport | 4.803 | 7.525 |
|
| |||
|
| |||
| 4 | L-Serine pathways and transport | 1.369 | 1.538 |
|
| |||
|
| |||
| 5 | (S)-Citrulline pathway | 1.636 | 1.538 |
|
| |||
| # | Downregulation: GO processes in common versus MCF7, SKBR3, and HCC1937 (107 genes) |
| FDR |
|
| |||
| 1 | Response to organic substance | 1.120 | 3.750 |
|
| |||
|
| |||
| 2 | Regulation of immune complex clearance by monocytes and macrophages | 4.480 | 4.999 |
|
| |||
|
| |||
| 3 | Positive regulation of immune complex clearance by monocytes and macrophages | 4.480 | 4.999 |
|
| |||
|
| |||
| 4 | Response to endogenous stimulus | 1.450 | 1.213 |
|
| |||
|
| |||
| 5 | Response to acid | 2.446 | 1.638 |
|
| |||
|
| |||
| # | Downregulation: metabolic networks in common versus MCF7, SKBR3, and HCC1937 (107 genes) |
| FDR |
|
| |||
| 1 | Steroid metabolism_cholesterol biosynthesis | 3.670 | 1.468 |
|
| |||
|
| |||
| 2 | GalNAcbeta1-3Gal pathway | 5.291 | 1.058 |
|
| |||
|
| |||
| 3 | N-Acyl-sphingosine phosphate pathway | 8.346 | 1.113 |
|
| |||
|
| |||
| 4 | Lipid metabolism_n-6 polyunsaturated fatty acid biosynthesis | 3.289 | 3.270 |
|
| |||
|
| |||
| 5 | Glucosylceramide pathways and transport | 5.067 | 3.270 |
|
| |||